Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
Fred Hutchinson Cancer Center has a Data Coordinator Lead position available through the Cancer Prevention Department. Specifically, this position is under the direction of Dr. Katrina Ortblad within the Division of Public Health Sciences at Fred Hutch. Dr. Ortblad’s research aims to improve equity in health access with differentiated models of HIV service delivery in high prevalence settings. Most of her work focuses on designing innovative models for HIV pre-exposure prophylaxis (PrEP) delivery with African research colleagues, refining these models using findings from qualitative research and stakeholder engagement, and then testing these models in pilot studies and later hybrid implementation-effectiveness trials. Dr. Ortblad’s research uses diverse methods across the fields of epidemiology, economics, public policy, psychology, and implementation science.
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq('init', '3151876674868105');
fbq('track', 'PageView');
Source link